December 20, 2012 – Despite estimates that Bayer has settled more than 3,500 lawsuits alleging blood clots from their Yaz and Yasmin birth controls, patients continue to come forward who are seeking to learn about their legal options.
Fortunately, indications from the drug maker and the court that is handling the settlements signify that they could extend into early to middle 2013.
The American College of Obstetricians and Gynecologists is the latest group to caution patients that birth control pills containing drospirenone such as Yaz and Yasmin can have higher risks of causing blood clots.
In October of 2011, the British Medical Journal and FDA published similar studies linking the hormone in Yaz to blood clots, saying drospirenone could increase occurrences by as much as 74%.
Blood clots have been related to serious conditions such as DVT, stroke and pulmonary embolism. Anyone who suffered similar injuries after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
Due to the number of Yaz lawsuits filed, cases were moved to a special federal Multi-District Litigation court in Illinois. With health warnings increasing, Bayer started settling certain claims in early 2012.
In its latest financial report, Bayer disclosed that as many as 13,000 Yaz lawsuits have been filed and that it has resolved as many as 3,500 of these so far. At a total cost of nearly $750 million, the average amount paid per case is around $214,000.
Fortunately, Bayer has indicated it will set aside more funds to resolve cases involving blood clots. Also, in July, the court officer appointed to oversee settlement negotiations for the federal court, special master Stephen Saltzburg, estimated the settlements could be concluded within a year, which would put a deadline as late as summer of 2013.
For now, Bayer has stated they are only settling claims involving blood clot injuries.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
DrugRisk cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer.